Zoetis (ZTS) Change in Inventory (2014 - 2026)
Zoetis (ZTS) posted quarterly Change in Inventory of $114.0 million for Q1 2026, up 34.12% year-over-year from $85.0 million in Q1 2025, and up 976.92% quarter-over-quarter from -$13.0 million in Q4 2025.
Zoetis (ZTS) Change in Inventory (2014 - 2026) Analysis & Trends
Zoetis (ZTS) has reported Change in Inventory for 13 consecutive years, with $114.0 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Change in Inventory rose 34.12% year-over-year to $114.0 million; the TTM figure through Mar 2026 stood at $228.0 million (up 744.44% YoY), while the FY2025 annual figure was $199.0 million, up 397.5% from the prior year.
- Change in Inventory improved to $114.0 million in Q1 2026 per ZTS's latest filing, from -$13.0 million in the prior quarter.
- Across five years, Change in Inventory topped out at $235.0 million in Q1 2023 and bottomed at -$136.0 million in Q4 2023.
- Historically, Change in Inventory has averaged $70.6 million across 5 years, with a median of $83.0 million in 2025.
- Annual changes were most pronounced in 2023 — Change in Inventory tumbled 383.33% — and 2025, when it surged 2300.0%.
- Zoetis' Change in Inventory stood at $48.0 million in 2022, then tumbled by 383.33% to -$136.0 million in 2023, then jumped by 46.32% to -$73.0 million in 2024, then surged by 82.19% to -$13.0 million in 2025, then soared by 976.92% to $114.0 million in 2026.
- Business Quant data shows ZTS's Change in Inventory at $114.0 million in Q1 2026, -$13.0 million in Q4 2025, and $44.0 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.98 Bn | 43.02 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.28 Bn | 39.62 Bn | 2.15 Bn | -59.00 Mn |
| 3 | Zoetis | 31.79 Bn | 30.11 Bn | 1.05 Bn | 23.00 Mn |
| 4 | Takeda Pharmaceutical | 28.69 Bn | 22.89 Bn | 5.10 Bn | -209.58 Mn |
| 5 | United Therapeutics | 22.25 Bn | 19.58 Bn | 683.80 Mn | 17.70 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | 99.50 Mn |
| 7 | Neurocrine Biosciences | 15.58 Bn | 15.19 Bn | 935.80 Mn | 6.50 Mn |
| 8 | Elanco Animal Health | 11.87 Bn | 11.34 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | - |
| 10 | Alkermes | 8.15 Bn | 7.49 Bn | 397.90 Mn | -7.44 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 23.00 Mn |
| Jun 30, 2026 | 23.00 Mn |
| Mar 31, 2026 | 114.00 Mn |
| Mar 31, 2026 | 114.00 Mn |
| Dec 31, 2025 | -13.00 Mn |
| Dec 31, 2025 | -13.00 Mn |
| Sep 30, 2025 | 44.00 Mn |
| Sep 30, 2025 | 44.00 Mn |
| Jun 30, 2025 | 83.00 Mn |
| Jun 30, 2025 | 83.00 Mn |
| Mar 31, 2025 | 85.00 Mn |
| Mar 31, 2025 | 85.00 Mn |
| Dec 31, 2024 | -73.00 Mn |
| Dec 31, 2024 | -73.00 Mn |
| Sep 30, 2024 | -2.00 Mn |
| Sep 30, 2024 | -2.00 Mn |
| Jun 30, 2024 | 17.00 Mn |
| Jun 30, 2024 | 17.00 Mn |
| Mar 31, 2024 | 98.00 Mn |
| Mar 31, 2024 | 98.00 Mn |